McAndrews, Held & Malloy Attorneys Recognized Among the World’s Leading Patent Practitioners for Fourth Consecutive Year


Shareholder Christopher V. Carani Featured For The First Time

CHICAGO, IL – June 25, 2015 – McAndrews, Held & Malloy founding partner and Chairman Timothy J. Malloy, along with shareholders Herbert D. Hart III, Edward A. Mas II, and Nabeela Rasheed, Ph.D., were featured for the fourth consecutive year in Intellectual Asset Management magazine’s (IAM) “IAM 1000: The World’s Leading Patent Practitioners.” This year also marks the first time Christopher V. Carani has been honored with this recognition. All five attorneys, who are listed in the guide’s litigation and prosecution categories, have contributed to the IP specialty law firm’s reputation as “passionate and dedicated litigators” who leverage “technical erudition to distil things down for judges and juries in a way that is highly persuasive.”

To compile the results, IAM conducted detailed interviews with hundreds of private practice attorneys and in-house counsel from all over the world. This included asking interviewees to name expert witnesses they seek for counsel on damages and technical issues. Attorneys qualified for the listing only if they received substantial positive feedback.

IAM refers to 2014 as a “pinnacle year” for the firm, scoring “vital wins for Abbott Labs and Stryker Corporation, among others.” Malloy and Mas were described as “the master builders behind many of the team’s victories.”  The firm’s strength in design patent litigation is embodied in “pre-eminent designs expert” Carani.

On the prosecution side, McAndrews, Held & Malloy is “celebrated for its timely delivery of clear, concise and easily implementable advice that chimes with the commercial interest of clients.” Hart was touted as a “first-rate post-grant know-how,” noting his “familiar and respected presence at the PTAB,” while Dr. Rasheed was recognized as a “thought leader on biological therapeutics and follow-on biologics.”

Nationally recognized for his intellectual property litigation successes, Timothy J. Malloy has been involved in numerous multimillion dollar verdicts, awards and settlements and has served as lead counsel in trials throughout the country. He has also engaged in numerous, highly successful arbitrations and mediations. For years, Malloy has been listed in Best Lawyers, Leading Lawyers and Chambers USA. In the 2015 Chambers USA rankings, Malloy was described as “a highly respected” IP professional, and “fantastic trial lawyer.” Malloy has been designated a Fellow of the Litigation Counsel of America, an honorary society comprised of less than one-half of one percent of American trial lawyers.

Herbert D. Hart III has litigated cases before the Patent Trial and Appeal Board (PTAB) over several decades and in a wide range of technologies, particularly life science and chemical technologies. He is a well-recognized PTAB practitioner, and he has served as an expert witness on interference practice. He often speaks on the intricacies of PTAB trial practice, as well as on rulemaking under the post-grant provisions of the Leahy-Smith America Invents Act. Hart has served in leadership positions in all three national intellectual property law associations and on the American Intellectual Property Law Association’s (AIPLA) Special Task Force on AIA Rulemaking. He was also appointed to the six-member Intellectual Property Owners Association/American Bar Association (ABA)/AIPLA Expert Committee on Regulations for Conducting New Post-Grant Review/Inter Partes Review Procedures (also known as the “Gang of 6”). He is widely published in the field of IP law and has provided commentary in numerous legal, business and scientific publications.

Edward A. Mas II works with clients in a wide range of technologies, with a special emphasis on medical devices. His practice focuses on patent litigation and other complex technology-related litigation, serving as lead counsel in numerous high-stake district court actions, appeals, and arbitrations. One of his professional highlights includes securing a $166 million dollar victory for Advanced Cardiovascular Systems, Inc., which rates among the top patent damages awards of all time. During the past several years, Mas has successfully defended multiple patent infringement suits on behalf of Abbott Labs, in which sales of the accused products exceeded $1 billion. In addition to medical devices, Mas’s litigation practice involves such diverse technologies as pharmaceuticals, biologics and related antibody expression systems, barcode scanners and printers, bicycle equipment, and automotive sensors. Mas also conducts patent reexaminations and other post-grant proceedings in the United States Patent and Trademark Office, client counseling, licensing, clearance opinions, and portfolio management.

Nabeela Rasheed, Ph.D., focuses on the acquisition and enforcement of intellectual property rights. She is the legal counselor of choice for companies seeking to identify, protect and maximize the value of their IP portfolios. Dr. Rasheed also represents Fortune 500, multinational companies whose products involve a broad range of traditional and emerging technologies in the acquisition and protection of intellectual property developed through joint ventures and strategic alliances, and conducts IP due diligence in relation to mergers, acquisitions and other transactions. She has extensive experience with opposition practice in the United States and Europe, and regularly represents clients in patent reexaminations, inter partes reviews and post-grant reviews. In addition, Dr. Rasheed serves as an independent consultant in matters involving inventorship and the prioritization of invention issues. She is a thought leader in biosimilar and generic pharmaceuticals, helping clients navigate the complex regulations against biological therapeutics and follow-on biologics, and avoid IP violations following the ACA.

Christopher V. Carani counsels clients on a wide range of strategic design protection and enforcement issues. He is the immediate past Chair of the ABA’s Design Rights Committee, and the past chair of the AIPLA’s Committee on Industrial Designs. He has litigated numerous disputes regarding design rights and has served as a legal consultant and expert witness in design law cases in a wide range of industries, including consumer electronics and accessories, consumer retail products, furniture, medical devices, apparel, footwear, and sporting goods, to name a few. In addition, Carani has authored amicus briefs for landmark U.S. design patent cases, such as Egyptian Goddess v. Swisa, Lawman Armor Corp. v. Winner Int’l LLC, Calmar, Inc. v. Arminak & Assoc. and Richardson v. Stanley Works, Inc. He is a frequent contributor to CNN on intellectual property law issues, and is often called upon to provide commentary to other major media outlets, including The New York Times, The Wall Street Journal, Forbes and NPR.


About McAndrews, Held & Malloy

McAndrews, Held & Malloy boasts one of the most highly regarded teams of intellectual property attorneys, agents and technology specialists in the United States. Founded in 1988, the firm offers deep bench strength in matters relating to patents, trademarks, copyrights, trade secrets and unfair competition. McAndrews attorneys have underlying scientific-based degrees and extensive prior experience in technology and IP-focused professions, and they routinely handle cases that involve innovative and cutting-edge technologies in specialized industries. While best known for their record of litigation successes, the firm also offers services in IP procurement, patent interferences, trademark oppositions and cancellations, IP/technology opinions and investigations, global portfolio management, development and licensing, M&A support, due diligence, design rights and joint ventures. Clients include multi-national corporations, Fortune 500 companies, startups and world-renowned universities. For more information, visit